Seguir
maria trojano
maria trojano
Dipartimento di Scienze Mediche di Base, Neuroscienze ed Organi di Senso, Università degli Studi
E-mail confirmado em uniba.it
Título
Citado por
Citado por
Ano
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
AJ Thompson, BL Banwell, F Barkhof, WM Carroll, T Coetzee, G Comi, ...
The Lancet Neurology 17 (2), 162-173, 2018
63922018
Multiple Sclerosis Severity Score: using disability and disease duration to rate disease severity
R Roxburgh, SR Seaman, T Masterman, AE Hensiek, SJ Sawcer, ...
Neurology 64 (7), 1144-1151, 2005
10482005
Cerebrospinal fluid in the diagnosis of multiple sclerosis: a consensus report.
M Andersson, J Alvarez-Cermeno, G Bernardi, I Cogato, P Fredman, ...
Journal of Neurology, Neurosurgery & Psychiatry 57 (8), 897-902, 1994
9501994
The genomic history of southeastern Europe
I Mathieson, S Alpaslan-Roodenberg, C Posth, A Szécsényi-Nagy, ...
Nature 555 (7695), 197-203, 2018
7092018
The incidence and prevalence of psychiatric disorders in multiple sclerosis: a systematic review
RA Marrie, S Reingold, J Cohen, O Stuve, M Trojano, PS Sorensen, ...
Multiple Sclerosis Journal 21 (3), 305-317, 2015
5642015
Diagnostic value of cerebrospinal fluid neurofilament light protein in neurology: a systematic review and meta-analysis
C Bridel, WN Van Wieringen, H Zetterberg, BM Tijms, CE Teunissen, ...
JAMA neurology 76 (9), 1035-1048, 2019
5292019
Disease‐modifying therapies and coronavirus disease 2019 severity in multiple sclerosis
MP Sormani, N De Rossi, I Schiavetti, L Carmisciano, C Cordioli, L Moiola, ...
Annals of neurology 89 (4), 780-789, 2021
4682021
Association of initial disease-modifying therapy with later conversion to secondary progressive multiple sclerosis
JWL Brown, A Coles, D Horakova, E Havrdova, G Izquierdo, A Prat, ...
Jama 321 (2), 175-187, 2019
4512019
Bedtime hypertension treatment improves cardiovascular risk reduction: the Hygia Chronotherapy Trial
RC Hermida, JJ Crespo, M Domínguez-Sardiña, A Otero, A Moya, ...
European heart journal 41 (48), 4565-4576, 2020
4232020
A systematic review of the incidence and prevalence of comorbidity in multiple sclerosis: overview
RA Marrie, J Cohen, O Stuve, M Trojano, PS Sørensen, S Reingold, ...
Multiple Sclerosis Journal 21 (3), 263-281, 2015
4172015
The Rao’s Brief Repeatable Battery and Stroop Test: normative values with age, education and gender corrections in an Italian population
MP Amato, E Portaccio, B Goretti, V Zipoli, L Ricchiuti, MF De Caro, F Patti, ...
Multiple Sclerosis Journal 12 (6), 787-793, 2006
4072006
Defining secondary progressive multiple sclerosis
J Lorscheider, K Buzzard, V Jokubaitis, T Spelman, E Havrdova, ...
Brain 139 (9), 2395-2405, 2016
3872016
Randomized placebo-controlled trial of mitoxantrone in relapsing-remitting multiple sclerosis: 24-month clinical and MRI outcome
E Millefiorini, C Gasperini, C Pozzilli, F D’andrea, S Bastianello, ...
Journal of neurology 244, 153-159, 1997
3781997
The prevalence of pain in multiple sclerosis: a multicenter cross-sectional study
C Solaro, G Brichetto, MP Amato, E Cocco, B Colombo, G D’aleo, ...
Neurology 63 (5), 919-921, 2004
3762004
Clinical characteristics, course and prognosis of relapsing Devic’s Neuromyelitis Optica
A Ghezzi, R Bergamaschi, V Martinelli, M Trojano, MR Tola, E Merelli, ...
Journal of neurology 251, 47-52, 2004
3682004
Conversion from clinically isolated syndrome to multiple sclerosis: a large multicentre study
J Kuhle, G Disanto, R Dobson, R Adiutori, L Bianchi, J Topping, ...
Multiple Sclerosis Journal 21 (8), 1013-1024, 2015
3602015
New natural history of interferon‐β–treated relapsing multiple sclerosis
M Trojano, F Pellegrini, A Fuiani, D Paolicelli, V Zipoli, GB Zimatore, ...
Annals of neurology 61 (4), 300-306, 2007
3582007
Cognitive and psychosocial features of childhood and juvenile MS
MP Amato, B Goretti, A Ghezzi, S Lori, V Zipoli, E Portaccio, L Moiola, ...
Neurology 70 (20), 1891-1897, 2008
3222008
Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): a phase 3, randomised, double-blind, placebo-controlled trial with an open …
R Kapoor, PR Ho, N Campbell, I Chang, A Deykin, F Forrestal, N Lucas, ...
The Lancet Neurology 17 (5), 405-415, 2018
3182018
Age and disability drive cognitive impairment in multiple sclerosis across disease subtypes
L Ruano, E Portaccio, B Goretti, C Niccolai, M Severo, F Patti, S Cilia, ...
Multiple Sclerosis Journal 23 (9), 1258-1267, 2017
3182017
O sistema não pode executar a operação agora. Tente novamente mais tarde.
Artigos 1–20